Full-Time

Senior Manager

Inspection Management, R&D Quality

Confirmed live in the last 24 hours

Moderna

Moderna

5,001-10,000 employees

Develops mRNA-based medicines and therapies

Biotechnology
Healthcare

Senior

Cambridge, MA, USA + 2 more

More locations: Princeton, NJ, USA | Bethesda, MD, USA

70% in-office presence required.

Category
Public Health
Biology Lab & Research
Biology & Biotech
Required Skills
Google Cloud Platform
Requirements
  • BS/BA, MS or PhD and a minimum of 10, 8, 6 years’ experience, respectively, in Biotech, Pharma or Clinical Research Organization.
  • Knowledge of relevant FDA, EU, ICH GCP guidelines, and applicable international GxP regulations, guidelines and local legislation.
  • Knowledge of relevant FDA, EU, guidance for computerized systems is a plus.
  • Experience with inspection coordination and logistical planning for regulatory authority inspections.
  • Strong communication and presentation skills, both verbal and written.
  • Experience developing responses to regulatory authority inspection findings.
  • Experience working with CROs, vendors, and relationship management.
  • Leadership skills with ability to effectively organize and execute tasks.
  • Ability to work both independently and in a team environment.
  • Strong analytical, problem solving and decision-making skills in a complex, fast-paced, and changing environment.
  • Ability to collaborate effectively in a dynamic, cross-functional matrix environment.
  • Ability to influence and negotiate effective solutions, excellent interpersonal skills.
  • A desire to make an impact as part of a high-growth, transformational company that is Bold, Relentless, Curious, and Collaborative.
  • Travel of up to 30% required.
Responsibilities
  • Builds and maintains strong and productive relationships with key stakeholders within R&D to support the successful and compliant execution of Moderna regulatory inspection activities.
  • Maintains in-depth knowledge of governmental regulations affecting GCP, GVP, GLP in the drug development process.
  • Plan, and coordinate GCP, GVP, GLP, GCLP regulatory authority inspections (routine, directed or submission driven) and the pre-inspection request process.
  • Coordinate and manage inspection preparation activities such as inspection management trainings, mock inspection interviews, mock inspections, site risk assessments and clinical site inspection preparation visits in preparation for regulatory authority inspections.
  • Provide guidance and direction in development of responses to observations resulting from inspections of Moderna’s R&D programs.
  • Ensure any critical and major inspection findings have appropriate Corrective and Preventative Actions (CAPA) and are tracked to completion and verification of effectiveness.
  • Lead and manage post-inspection lesson’s learned sessions, ensuring all actions are tracked to completion.
  • Contributes to and maintains inspection management plans, trainings, and strategies for the R&D Quality inspection management program.
  • Review and provide input into study team inspection preparation activities, storyboards, etc.
  • Collaborates with industry through benchmarking of regulatory activities that may influence regulatory inspection activities and strategies.
  • Contribute to the ongoing operations of the R&D Quality Regulatory Intelligence Program in issuance of multi-discipline monthly briefing reports to the organization.
  • Provide input into the issue management program to ensure early detection of issues, development of appropriate and robust corrective and preventative actions (CAPA), tracking of CAPA completion, and assessment of effectiveness is attained.
  • Support RDQ projects and initiatives, as assigned.
  • Provides mentoring for new and junior staff members, as assigned.
  • Contribute to the continuing development of a quality culture at Moderna.

Moderna focuses on developing medicines using messenger RNA (mRNA), which is a molecule that provides instructions for cells to produce proteins essential for various biological functions. Their approach involves creating a new class of medicines that leverage mRNA to potentially enhance the discovery, development, and manufacturing of drugs. Unlike traditional methods, which often rely on proteins or other biological materials, Moderna's use of mRNA allows for a more versatile and efficient way to create treatments. The company's goal is to improve patient outcomes by harnessing the power of mRNA to address a wide range of health issues.

Company Stage

Grant

Total Funding

$5.9B

Headquarters

Cambridge, Massachusetts

Founded

N/A

Growth & Insights
Headcount

6 month growth

3%

1 year growth

12%

2 year growth

54%
Simplify Jobs

Simplify's Take

What believers are saying

  • Moderna's expansion into combination vaccines and autoimmune therapies showcases its potential for diversified revenue streams and market leadership.
  • The company's continuous innovation and FDA approvals for updated COVID-19 vaccines highlight its resilience and adaptability in a rapidly changing market.
  • Moderna's educational initiatives, like the free mRNA course, position it as a thought leader and advocate for mRNA technology.

What critics are saying

  • The collapse in demand for COVID-19 vaccines could significantly impact Moderna's revenue and growth prospects.
  • Ongoing class action lawsuits alleging securities fraud could damage Moderna's reputation and financial stability.

What makes Moderna unique

  • Moderna is pioneering the use of mRNA technology to create a new class of medicines, setting it apart from traditional pharmaceutical companies.
  • The company's focus on mRNA as the 'software of life' allows for rapid development and manufacturing of vaccines and therapies, unlike conventional methods.
  • Moderna's ability to secure regulatory approvals for mRNA vaccines beyond COVID-19, such as for RSV, demonstrates its leadership in mRNA technology.

Help us improve and share your feedback! Did you find this helpful?